Insider Transactions in Q3 2025 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 06
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
60,000
-26.09%
|
$3,180,000
$53.58 P/Share
|
|
Aug 01
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
250
-0.09%
|
$16,000
$64.44 P/Share
|
|
Aug 01
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+0.09%
|
$2,750
$11.53 P/Share
|
|
Jul 31
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
26,350
-8.64%
|
$1,765,450
$67.0 P/Share
|
|
Jul 31
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,350
+2.15%
|
$237,150
$9.32 P/Share
|
|
Jul 28
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.63%
|
$149,176
$58.7 P/Share
|
|
Jul 24
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,100
-0.75%
|
$119,700
$57.52 P/Share
|
|
Jul 24
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+0.74%
|
$10,500
$5.01 P/Share
|
|
Jul 23
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,750
-4.7%
|
$770,000
$56.0 P/Share
|
|
Jul 23
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+1.51%
|
$96,250
$7.79 P/Share
|
|
Jul 21
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
125,335
-24.27%
|
$6,141,415
$49.5 P/Share
|
|
Jul 21
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+19.11%
|
$250,670
$2.43 P/Share
|
|
Jul 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-10.06%
|
$2,376,700
$50.53 P/Share
|
|
Jul 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,792
-2.94%
|
$139,600
$50.58 P/Share
|
|
Jul 14
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-17.64%
|
$544,307
$47.7 P/Share
|
|
Jul 14
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,587
+10.36%
|
$37,935
$5.01 P/Share
|
|
Jul 14
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.6%
|
$120,884
$47.82 P/Share
|
|
Jul 07
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-16.63%
|
$532,726
$46.67 P/Share
|
|
Jul 07
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+8.46%
|
$32,185
$5.01 P/Share
|